acyclovir

Generic: acyclovir

Labeler: st. mary's medical park pharmacy
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir
Generic Name acyclovir
Labeler st. mary's medical park pharmacy
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

acyclovir 200 mg/1

Manufacturer
St. Mary's Medical Park Pharmacy

Identifiers & Regulatory

Product NDC 60760-606
Product ID 60760-606_cdb55e30-057a-5d3b-e053-2a95a90ae79c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204313
Listing Expiration 2026-12-31
Marketing Start 2021-08-30

Pharmacologic Class

Established (EPC)
herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc]
Mechanism of Action
dna polymerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 60760606
Hyphenated Format 60760-606

Supplemental Identifiers

RxCUI
197310
UNII
X4HES1O11F
NUI
N0000020060 N0000180187 N0000180188 N0000175468 N0000175459

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA204313 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE, PLASTIC (60760-606-60)
source: ndc

Packages (1)

Ingredients (1)

acyclovir (200 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "cdb55e30-057a-5d3b-e053-2a95a90ae79c", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["cdb55e30-0579-5d3b-e053-2a95a90ae79c"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["St. Mary's Medical Park Pharmacy"]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE, PLASTIC (60760-606-60)", "package_ndc": "60760-606-60", "marketing_start_date": "20210830"}], "brand_name": "acyclovir", "product_id": "60760-606_cdb55e30-057a-5d3b-e053-2a95a90ae79c", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "60760-606", "generic_name": "acyclovir", "labeler_name": "St. Mary's Medical Park Pharmacy", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA204313", "marketing_category": "ANDA", "marketing_start_date": "20210830", "listing_expiration_date": "20261231"}